Villiger J W, Ray L J, Taylor K M
Neuropharmacology. 1983 Apr;22(4):447-52. doi: 10.1016/0028-3908(83)90162-4.
The present study characterises the binding of the highly lipophilic opiate agonist [3H]fentanyl to homogenates of the rat central nervous system. At 25 degrees C, association of [3H]fentanyl with its binding site was rapid (t1/2 = 2.5 min). Dissociation from the binding site was biphasic (t1/2's = 4.0 and 100 min) suggesting the existence of high and low affinity binding sites. Scatchard plots of saturation isotherms were curvilinear, confirming the presence of high (KD = 0.46 nM) and low KD = 4.26 nM) affinity binding sites. Increasing temperature and the concentration of sodium ion decreased the [3H]fentanyl binding. Opiate agonists, antagonists and mixed agonist-antagonists were all potent (IC50's less than 20 nM) in displacing [3H]fentanyl and displacement by levorphanol and dextrorphan indicated that [3H]fentanyl binding was stereospecific. The mu and delta selective peptides, morphiceptin and [D-Ala2,D-Leu5]enkephalin, had IC50 values of 87 and 9.2 nM respectively. The regional distribution of [3H]fentanyl binding was in the rank order striatum approximately equal to midbrain greater than hypothalamus greater than cortex greater than hippocampus greater than brainstem greater than spinal cord greater than cerebellum. Comparison of [3H]fentanyl, [3H]naloxone and [3H-D-Ala2,D-Leu5]enkephalin binding in the hypothalamus-thalamus (mu-enriched) compared with the frontal cortex-striatum (delta-enriched) indicated that the pattern of [3H]fentanyl labelling was similar to that obtained with [3H]naloxone, but differed from that obtained with [3H-D-Ala2,D-Leu5]enkephalin. These characteristics suggest that [3H]fentanyl binds to the mu-opiate receptor. These findings are discussed in relation to the high lipid solubility of fentanyl as compared with morphine.
本研究对高度亲脂性阿片类激动剂[3H]芬太尼与大鼠中枢神经系统匀浆的结合特性进行了表征。在25℃时,[3H]芬太尼与其结合位点的结合迅速(t1/2 = 2.5分钟)。从结合位点的解离是双相的(t1/2分别为4.0和100分钟),这表明存在高亲和力和低亲和力结合位点。饱和等温线的Scatchard图呈曲线状,证实了高亲和力(KD = 0.46 nM)和低亲和力(KD = 4.26 nM)结合位点的存在。温度升高和钠离子浓度增加会降低[3H]芬太尼的结合。阿片类激动剂、拮抗剂和混合激动剂 - 拮抗剂在取代[3H]芬太尼方面都具有强效(IC50小于20 nM),左啡诺和右啡烷的取代表明[3H]芬太尼的结合具有立体特异性。μ和δ选择性肽,吗啡肽和[D - Ala2,D - Leu5]脑啡肽的IC50值分别为87和9.2 nM。[3H]芬太尼结合的区域分布顺序为纹状体≈中脑>下丘脑>皮质>海马>脑干>脊髓>小脑。与额叶皮质 - 纹状体(富含δ)相比,下丘脑 - 丘脑(富含μ)中[3H]芬太尼、[3H]纳洛酮和[3H - D - Ala2,D - Leu5]脑啡肽结合的比较表明,[3H]芬太尼标记模式与[3H]纳洛酮相似,但与[3H - D - Ala2,D - Leu5]脑啡肽不同。这些特性表明[3H]芬太尼与μ阿片受体结合。结合芬太尼与吗啡相比具有高脂质溶解度这一点,对这些发现进行了讨论。